Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.

about

Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.

Item

http://www.wikidata.org/entity/Q48265668

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognostic factors for surviva ...... : a decision-tree-based model.

@en

Prognostic factors for surviva ...... : a decision-tree-based model.

@nl

type

Item

label

Prognostic factors for surviva ...... : a decision-tree-based model.

@en

Prognostic factors for surviva ...... : a decision-tree-based model.

@nl

prefLabel

Prognostic factors for surviva ...... : a decision-tree-based model.

@en

Prognostic factors for surviva ...... : a decision-tree-based model.

@nl

P1476

Prognostic factors for surviva ...... : a decision-tree-based model.

@en

P2093

Adeline Riondel

http://www.w3.org/2001/XMLSchema#string

Alexandre Roux

http://www.w3.org/2001/XMLSchema#string

Anaïs Chivet

http://www.w3.org/2001/XMLSchema#string

Antoine Carpentier

http://www.w3.org/2001/XMLSchema#string

Antoine Petit

http://www.w3.org/2001/XMLSchema#string

Club de Neuro-Oncologie of the Société Française de Neurochirurgie

http://www.w3.org/2001/XMLSchema#string

Edouard Dezamis

http://www.w3.org/2001/XMLSchema#string

Elodie Sorbets

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Lechapt-Zalcman

http://www.w3.org/2001/XMLSchema#string

Evelyne Emery

http://www.w3.org/2001/XMLSchema#string

P2860

Random Forests

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials

A comparison of treatment results for recurrent malignant gliomas.

Recurrent malignant gliomas.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.

Standards of care for treatment of recurrent glioblastoma--are we there yet?

P2888

s11060-017-2685-4

P304

565-576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2685-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29159777

http://www.w3.org/2001/XMLSchema#string